Earnings Outlook For Exagen
Portfolio Pulse from Benzinga Insights
Exagen (NASDAQ:XGN) is scheduled to release its quarterly earnings report on March 18, 2024, with analysts expecting an EPS of $-0.43. The company's past performance shows a pattern of beating EPS estimates, leading to significant share price movements. Shares are currently trading at $1.72, down 25.89% over the last year. Investors are looking for positive guidance for the next quarter, which could influence the stock price more than the earnings beat or miss.
March 15, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exagen is expected to report an EPS of $-0.43 for the latest quarter, with a history of beating estimates and influencing stock prices significantly. Currently trading at $1.72, the stock has seen a 25.89% decline over the past year.
Given Exagen's history of beating EPS estimates and the subsequent positive impact on its stock price, there is a potential for a short-term price increase, especially if the company provides positive future guidance. However, the stock's overall negative performance over the past year indicates a cautious optimism.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100